The leading market experts have placed a mean price target of $149.63 on Laboratory Corporation of America Holdings (NYSE:LH) stock. This price level, which is estimated to be attained in one-year, indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $2.19 a share for the upcoming quarter and $8.82 for the current fiscal.
The technical analysis of Laboratory Corporation of Ameri plainly substantiates that the 50-day moving average of Laboratory Corporation of Ameri is $134.81, and stock is trading $5.21 points away or +3.87% from its 50-day moving average of $134.81. Further it is trading $17.62 or +14.40% away its 200-day moving average of $122.40. Laboratory Corporation of America Holdings (NYSE:LH) 52-week high is $141.32 and the 52-week low is $97.79.
This explains if the stock moves $-1.30, it will post a 52-week high. In event of +43.18% decline, a 52-week low will be hit.
Taking the valuation aspect to emphasize the valuation of Laboratory Corporation of Ameri, shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Laboratory Corporation of America Holdings (NYSE:LH) ratio came in at 23.25.
The stock last ended the trading session at $140.02 and registered a market cap of $14.32B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Laboratory Corporation of America Holdings (NYSE:LH) PEG ratio is at 1.57.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...